kernel

Kernel is a company that researches human intelligence, focusing on the development of neuroprosthetic technologies to implant relevant devices in the human brain, unlocking the power of the human brain and enhancing cognitive abilities. Kernel is committed to researching a method of electrical impulses that can simultaneously measure and stimulate many neurons. This technology will be used for clinical treatment of diseases such as depression or Alzheimer's disease. In the second quarter of 2020, Kernel announced the full commercial availability of its Neuroscience as a Service (NaaS) platform, which allows customers to access world-record brain imaging equipment and conduct remote experiments.The combination of Kernel’s cutting-edge custom hardware with the innovative NaaS ecosystem has opened up numerous industries by accelerating unprecedented advancements in relatively low-cost, quantifiable, scalable, and high-fidelity neural data acquisition, including: biomarkers for cognition and brain health; improved AI for challenging tasks such as computer vision, attention, translation, natural language processing, or any other field where the human brain remains the gold standard; driving population-level neuroscience insights into consumer or societal choices and preferences; and consumer-grade brain-computer interfaces.